Demonstration study for defined ART system using recombinant human albumin

Demonstration study for defined ART system using recombinant human albumin - Demonstration study for defined ART system

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019838

Enrollment

100

Registered

2015-11-18

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients receiving ART treatmetns

Interventions

Embryo culture in commercial media supplemented with recombinant human albumin (0.5 mg/mL rHA) for 6 days Embryo culture in commercial media supplemented with human serum albumin (5 mg/mL HSA) for 6 d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with 4 or more 2PN oocytes after ART treatments using defined media

Exclusion criteria

Exclusion criteria: Oligozoospermia

Design outcomes

Primary

Measure	Time frame
Blastocyst rate, clinical pregnancy rate	—

Secondary

Measure	Time frame
Live birth rate	—

Countries

Japan

Contacts

Public ContactMasao Murakami

Kumamoto Women's Clinic Research Laboratory

murakami@kuramoto.or.jp092-482-5558

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026